190 related articles for article (PubMed ID: 30053477)
1. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
[TBL] [Abstract][Full Text] [Related]
2. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
[TBL] [Abstract][Full Text] [Related]
3. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.
Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297
[TBL] [Abstract][Full Text] [Related]
4. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
[TBL] [Abstract][Full Text] [Related]
5. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
6. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
[TBL] [Abstract][Full Text] [Related]
7. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
[TBL] [Abstract][Full Text] [Related]
8. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
9. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
Tzaridis S; Friedlander M;
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
[TBL] [Abstract][Full Text] [Related]
10. ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Zeimer M; Gutfleisch M; Heimes B; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2015 Nov; 35(11):2307-16. PubMed ID: 26465618
[TBL] [Abstract][Full Text] [Related]
11. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
[TBL] [Abstract][Full Text] [Related]
12. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
13. Comparison of macular pigment in three types of macular telangiectasia.
Sawa M; Gomi F; Ueno C; Suzuki M; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):689-96. PubMed ID: 22790309
[TBL] [Abstract][Full Text] [Related]
14. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
15. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
16. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.
Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012
[TBL] [Abstract][Full Text] [Related]
17. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1.
Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y
BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510
[TBL] [Abstract][Full Text] [Related]
18. LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.
Heeren TFC; Kitka D; Florea D; Clemons TE; Chew EY; Bird AC; Pauleikhoff D; Charbel Issa P; Holz FG; Peto T
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S20-S26. PubMed ID: 28541959
[TBL] [Abstract][Full Text] [Related]
19. Re-accumulation of macular pigment after successful macular hole surgery.
Bottoni F; Zanzottera E; Carini E; Cereda M; Cigada M; Staurenghi G
Br J Ophthalmol; 2016 May; 100(5):693-8. PubMed ID: 26338959
[TBL] [Abstract][Full Text] [Related]
20. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Zeimer MB; Sallo FB; Spital G; Heimes B; Lommatzsch A; Pauleikhoff D
Retina; 2016 Mar; 36(3):535-44. PubMed ID: 26398690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
